• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙拮抗剂对肾脏血流动力学对血管收缩剂反应的调节作用。

Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.

作者信息

Loutzenhiser R, Epstein M

机构信息

Nephrology Section, Veterans Administration Medical Center, Miami, Fla.

出版信息

Am J Nephrol. 1987;7 Suppl 1:7-16. doi: 10.1159/000167536.

DOI:10.1159/000167536
PMID:3442293
Abstract

Theoretical considerations suggest that the renal response to calcium antagonists may vary depending on the factors influencing basal vascular tone. Studies were conducted using the isolated perfused rat kidney to determine the response to calcium antagonists under conditions in which the determinants of renal vascular tone were accurately defined. With this model, calcium antagonists elicit vasodilation only in the presence of a vasoconstrictor. In this setting, however, the degree of vasodilation elicited depends on the nature of the vasoconstrictor employed. Thus, the reduction in renal perfusate flow (RPF) elicited by KCl-induced depolarization was completely reversed by the calcium antagonist, nitrendipine. In contrast, identical levels of vasoconstriction elicited by norepinephrine or angiotensin II were only partially reversed, suggesting that these agonists activate the renal vasculature by mechanisms that are more complex than membrane depolarization. Examination of the response of glomerular filtration rate (GFR) revealed that in the presence of norepinephrine and angiotensin II, nitrendipine exerted a preferential augmentation of GFR. Thus, concentrations that produced only modest effects on RPF increased GFR to levels equal to or exceeding control values. This selective augmentation of GFR did not occur during the renal vasoconstriction elicited by KCl. It is proposed that renal microvessels exhibit regional heterogeneity in regard to activation mechanisms and sensitivity to calcium antagonists. Calcium antagonists may selectively attenuate agonist-induced vasoconstriction of preglomerular vessels.

摘要

理论上的考虑表明,肾脏对钙拮抗剂的反应可能会因影响基础血管张力的因素而有所不同。研究采用离体灌注大鼠肾脏,以确定在肾脏血管张力决定因素被准确定义的条件下对钙拮抗剂的反应。利用该模型,钙拮抗剂仅在存在血管收缩剂的情况下才会引起血管舒张。然而,在这种情况下,所引起的血管舒张程度取决于所使用的血管收缩剂的性质。因此,由氯化钾诱导的去极化所引起的肾灌注液流量(RPF)的降低被钙拮抗剂尼群地平完全逆转。相比之下,由去甲肾上腺素或血管紧张素II引起的相同程度的血管收缩仅被部分逆转,这表明这些激动剂通过比膜去极化更复杂的机制激活肾血管系统。对肾小球滤过率(GFR)反应的检查显示,在存在去甲肾上腺素和血管紧张素II的情况下,尼群地平对GFR有优先增强作用。因此,对RPF仅产生适度影响的浓度可将GFR提高到等于或超过对照值的水平。在氯化钾引起的肾血管收缩过程中,并未出现这种对GFR的选择性增强。有人提出,肾微血管在激活机制和对钙拮抗剂的敏感性方面表现出区域异质性。钙拮抗剂可能会选择性地减弱激动剂诱导的肾小球前血管的血管收缩。

相似文献

1
Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.钙拮抗剂对肾脏血流动力学对血管收缩剂反应的调节作用。
Am J Nephrol. 1987;7 Suppl 1:7-16. doi: 10.1159/000167536.
2
Modification by dihydropyridine-type calcium antagonists of the renal hemodynamic response to vasoconstrictors.二氢吡啶类钙拮抗剂对肾脏血流动力学对血管收缩剂反应的影响。
J Cardiovasc Pharmacol. 1987;9 Suppl 1:S70-5.
3
Calcium antagonists and the renal hemodynamic response to vasoconstrictors.钙拮抗剂与肾脏对血管收缩剂的血流动力学反应
Ann N Y Acad Sci. 1988;522:771-84. doi: 10.1111/j.1749-6632.1988.tb33428.x.
4
Renal microvascular actions of calcium antagonists.钙拮抗剂的肾微血管作用。
J Am Soc Nephrol. 1990 Sep;1(3 Suppl 1):S3-12.
5
Renal hemodynamic effects of calcium antagonists.钙拮抗剂对肾脏血流动力学的影响。
Am J Cardiol. 1989 Sep 19;64(11):41F-45F. doi: 10.1016/0002-9149(89)90745-5.
6
Effects of amlodipine on renal hemodynamics.
Am J Cardiol. 1989 Nov 7;64(17):122I-127I; discussion 127I-128I. doi: 10.1016/0002-9149(89)90969-7.
7
Effects of diltiazem and manganese renal hemodynamics: studies in the isolated perfused rat kidney.地尔硫䓬和锰对肾血流动力学的影响:在离体灌注大鼠肾脏中的研究。
Nephron. 1985;39(4):382-8. doi: 10.1159/000183410.
8
Calcium antagonists and the kidney.钙拮抗剂与肾脏
Tohoku J Exp Med. 1992 Jan;166(1):123-34. doi: 10.1620/tjem.166.123.
9
Effects of calcium antagonists on renal hemodynamics.钙拮抗剂对肾脏血流动力学的影响。
Am J Kidney Dis. 1990 Oct;16(4 Suppl 1):10-4.
10
Renal interactions between norepinephrine and calcium antagonists.去甲肾上腺素与钙拮抗剂之间的肾脏相互作用。
Kidney Int. 1984 Nov;26(5):719-24. doi: 10.1038/ki.1984.207.

引用本文的文献

1
Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.Rho激酶抑制作用可降低压力介导的入球小动脉直径的自身调节性调整。
Am J Physiol Renal Physiol. 2009 Mar;296(3):F590-7. doi: 10.1152/ajprenal.90703.2008. Epub 2009 Jan 7.
2
Effects of a selective adenosine A1 receptor antagonist on the development of cyclosporin nephrotoxicity.一种选择性腺苷A1受体拮抗剂对环孢素肾毒性发展的影响。
Br J Pharmacol. 1996 Mar;117(5):879-84. doi: 10.1111/j.1476-5381.1996.tb15275.x.
3
Do calcium channel blockers have renal protective effects?
钙通道阻滞剂有肾脏保护作用吗?
Drugs Aging. 1994 Oct;5(4):263-87. doi: 10.2165/00002512-199405040-00004.
4
Renal effects of calcium entry blockers.钙通道阻滞剂对肾脏的影响。
Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:979-82. doi: 10.1007/BF02018304.
5
Intrarenal infusion of gallopamil in acute renal failure. A preliminary report.急性肾衰竭时肾内输注加洛帕米:初步报告
Drugs. 1991;42 Suppl 1:44-50. doi: 10.2165/00003495-199100421-00009.